Skip to search boxSkip to navigationSkip to main content

Germline mutation and aberrant transcripts of WWOX in a syndrome with multiple primary tumors

  • Ao Xu
    ,
  • Wei Wang
    ,
  • Jinfu Nie
    ,
  • ,
  • Bo Hong(corresponding author)
    ,
  • Wenchu Lin
*Corresponding author for this work
  • University of Science and Technology of China
    ,
  • Anhui Provincial Hospital
    ,
  • Chinese Academy of Sciences
    ,
  • CAS - Hefei Institutes of Physical Sciences
    ,
  • CAS - Guangzhou Institute of Biomedicine and Health
    ,
  • Chinese University of Hong Kong
Scholary Output:
Contribution to journal
Article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Multiple primary tumors are defined by the presence of two or more independent primary tumors in the same or different organs of an individual patient. However, the underlying genetic cause for the development of multiple primary tumors is largely unknown. In the study, we report a rare case with four synchronous distinct histological cancer types in a 26 years old Chinese female. In the patient, whole-exome sequencing identified a homozygous germline insertion mutation in WWOX which encodes the DNA repair-related enzyme, WW domain containing oxidoreductase. The mutation was found in a heterozygous state in her parents and brother without any cancer phenotype thus far. Surprisingly, we found multiple novel aberrant WWOX transcripts in the patient's normal colon tissue. The patient's colon metastasis from clear cell adenocarcinoma of the ovary showed a nonhypermutated profile enriched for C-T transition, and harbored somatic pathogenic mutations of HRAS, BRCA2, SMAD4, CHEK2, and AKT1 genes. To our knowledge, this is the first study reporting WWOX gene aberrations in a young patient with the early occurrence of multiple primary tumors.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 19-25 (7 pages)

Journal (Volume, Issue Number)

Journal of Pathology (Volume 249, Issue 1)

Publication milestones

  • Published - 09/2019

Publication status

Published - 09/2019

ISSN

0022-3417

Publication IDs

  • Scopus: 85067502975
  • PubMed: 31056747

Publication metrics

Metrics

Fractional count
1
Fractional count
0.17
Fractional count
5
Fractional count
0.83
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
6
Captures
12

Funding Details

This study was supported by National Natural Science Foundation of China (Grant Numbers: 81872438, 81702954, 81672647, 81502632, and 81372214), Natural Science Foundation of Anhui Province (Grant Number: 1608085MH179), Science and Technology Service Network Initiative of Chinese Academy of Sciences (Grant Number: KFJ-STS-SCYD-010), Science and Technology Major Project of Anhui Province (Grant Number: 18030801140), Key program of 13th five-year plan of CASHIPS (Grant Number: KP-2017-26), and the 100-Talent Program of Chinese Academy of Sciences. VWYL is funded by the Research Grant Council, Hong Kong (General Research Fund #17114814, #17121616, #14168517; Theme-based Research Scheme: T12-401/13-R), Health and Medical Research Fund, the Food and Health Bureau, The Government of the Hong Kong Special Administrative Region (HMRF #15160691), University Industry Collaboration Fund (UIM/329) by Lee’s Pharmaceutical and the Innovation and Technology Fund, The Hong Kong Government; the Hong Kong Cancer Fund, and the Start-up Fund from the School of Biomedical Sciences, the Chinese University of Hong Kong, Hong Kong SAR. This study was supported by National Natural Science Foundation of China (Grant Numbers: 81872438, 81702954, 81672647, 81502632, and 81372214), Natural Science Foundation of Anhui Province (Grant Number: 1608085MH179), Science and Technology Service Network Initiative of Chinese Academy of Sciences (Grant Number: KFJ-STS-SCYD-010), Science and Technology Major Project of Anhui Province (Grant Number: 18030801140), Key program of 13th five-year plan of CASHIPS (Grant Number: KP-2017-26), and the 100-Talent Program of Chinese Academy of Sciences. VWYL is funded by the Research Grant Council, Hong Kong (General Research Fund #17114814, #17121616, #14168517; Theme-based Research Scheme: T12-401/13-R), Health and Medical Research Fund, the Food and Health Bureau, The Government of the Hong Kong Special Administrative Region (HMRF #15160691), University Industry Collaboration Fund (UIM/329) by Lee's Pharmaceutical and the Innovation and Technology Fund, The Hong Kong Government; the Hong Kong Cancer Fund, and the Start-up Fund from the School of Biomedical Sciences, the Chinese University of Hong Kong, Hong Kong SAR.
FundersFunding numbers
Hong Kong Government
-
Key program of 13th five-year plan of CASHIPS
KP-2017-26
Research Grant Council, Hong Kong
17121616, 14168517, 17114814, T12-401/13-R
School of Biomedical Sciences
-
University Industry Collaboration Fund
UIM/329
NSFC
81702954, 81672647, 81372214, 81502632, 81872438
CAS
KFJ-STS-SCYD-010
RGC, UGC
-
Natural Science Foundation of Anhui Province
1608085MH179
CUHK
-
FHB
15160691
HMRF
-
ITF
-
Major Science and Technology Project of Hainan Province
18030801140
HKFC
-
HK
-
Major Science and Technology Projects in Anhui Province
-